Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Deferred Taxes (2021 - 2026)

Strata Critical Medical (SRTA) reported Deferred Taxes of -$77000.0 for Q1 2026, down 352.94% year-over-year from $30441.9 in Q1 2025, and up 38.89% on a QoQ basis from -$126000.0 in Q4 2025.

Strata Critical Medical (SRTA) has 5 years of Deferred Taxes data on file, last reported at -$77000.0 in Q1 2026.

  • Quarterly Deferred Taxes fell 352.94% year-over-year to -$77000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $372000.0 (up 297.87% YoY) and the FY2025 annual result came in at $432000.0, up 269.41% from the prior year.
  • Deferred Taxes climbed to -$77000.0 in Q1 2026 per SRTA's latest filing, from -$126000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $554000.0 in Q3 2025 and bottomed at -$1.0 million in Q4 2023.
  • The 4-year median for Deferred Taxes is -$84000.0 (2024), against an average of -$105076.9.
  • The widest annual swing landed in 2025, when Deferred Taxes surged 569.49%; it then tumbled 352.94% in 2026.
  • Tracing SRTA's Deferred Taxes over 4 years: stood at -$1.0 million in 2023, then jumped by 89.74% to -$105000.0 in 2024, then fell by 20.0% to -$126000.0 in 2025, then surged by 38.89% to -$77000.0 in 2026.
  • Per Business Quant, the three latest SRTA Deferred Taxes figures stand at -$77000.0 (Q1 2026), -$126000.0 (Q4 2025), and $554000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 435.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -40.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 54.80 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 8.50 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -104.77 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 3.89 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -4.74 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -12.46 Mn
10 Strata Critical Medical 538.39 Mn 479.60 Mn 14.12 Mn -77,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -77,000.00
Dec 31, 2025 -126,000.00
Sep 30, 2025 554,000.00
Jun 30, 2025 21,000.00
Mar 31, 2025 -17,000.00
Dec 31, 2024 -105,000.00
Sep 30, 2024 -118,000.00
Jun 30, 2024 52,000.00
Mar 31, 2024 -84,000.00
Dec 31, 2023 -1.02 Mn
Sep 30, 2023 129,000.00
Jun 30, 2023 -376,000.00
Mar 31, 2023 -196,000.00
Sep 30, 2021 -3.64 Mn